Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries
PLOS Neglected Tropical Diseases · 08.05.2026 · 20 (5) · e0014310
DOI: 10.1371/journal.pntd.0014310 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 08.05.2026. Verfasst von Larissa de Carvalho Medrado Vasconcelos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Public Health Laboratory (LASP), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ-BA), Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi, Antibodies, Protozoan, Immunoglobulin G. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordination for the Improvement of Higher Education Personnel, INOVA Fiocruz – Clinical Research in Chagas Disease, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Chagas disease (CD) remains a major public health challenge in Latin America, largely due to persistent underdiagnosis, particularly in endemic and resource-limited settings. Rapid diagnostic tests (RDTs) offer a pragmatic approach to expand serological screening; however, their performance varies across epidemiological contexts and parasite genetic backgrounds. The TR Chagas Bio-Manguinhos test, based on recombinant chimeric antigens, has shown high sensitivity in previous evaluations, but data from Southern Cone remain limited. We conducted a cross-sectional diagnostic accuracy study using 311 anonymized human plasma samples obtained in Argentina, including 233 Trypanosoma cruzi –positive and 78 negative samples classified by a composite reference standard based on at least two independent serological assays. Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test was assessed in terms of sensitivity, specificity, accuracy, likelihood ratios, diagnostic odds ratio, and agreement. Sensitivity was further stratified by country of origin (Argentina, Bolivia, Paraguay) and by cardiac involvement according to the Kuschnir classification. The TR Chagas Bio-Manguinhos test demonstrated high overall performance, with a sensitivity of 97.0% (95% CI: 93.9–98.5%), specificity of 94.9% (95% CI: 87.5–98.0%), and accuracy of 96.5% (95% CI: 93.8–98.0%). Agreement with the reference standard was almost perfect (κ = 0.91). Sensitivity remained consistently high across geographical origins and Kuschnir cardiac stages, with no statistically significant differences between subgroups. The negative likelihood ratio (0.03) indicated strong ability to rule out infection. These findings provide the first independent evidence supporting the high performance of the TR Chagas Bio-Manguinhos test in people from Argentina, Bolivia and Paraguay. The combination of very high sensitivity and robust specificity supports its use as a frontline serological screening tool for chronic T. cruzi infection in the Southern Cone, provided that reactive results are subsequently confirmed by laboratory- based assays in accordance with international guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Advanced Public Health Laboratory (LASP), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ-BA), Salvador, Bahia, Brazil.
- Interdisciplinary Research Group in Biotechnology and Epidemiology of Infectious Diseases (GRUPIBE), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ-BA), Salvador, Bahia, Brazil.
- Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres" (INGEBI-CONICET), Buenos Aires, Argentina.
- Immunobiological Technology Institute (Bio-Manguinhos), Oswaldo Cruz Foundation (FIOCRUZ-RJ), Rio de Janeiro, Rio de Janeiro, Brazil.
- Hospital General de Agudos "Dr. Ignacio Pirovano", Buenos Aires, Argentina.
- Instituto Nacional de Parasitología "Dr. Mario Fatala Chabén", Buenos Aires, Argentina.
ORCID-Profile: Fred Luciano Neves Santos
Förderung
- Coordination for the Improvement of Higher Education Personnel
- INOVA Fiocruz – Clinical Research in Chagas Disease
- National Council for Scientific and Technological Development
- Bahia Research Foundation
Zitieren
APA
Vasconcelos, L. C. M., Ossowski, M. S., Silva, E. D., Sampaio, D. D., Pavan, T. B. S., Ferreira, R. Q. V., Jesus, F. S. S., Chadi, R., Fernández, M. L., Hernández, Y., Gómez, K. A., & Santos, F. L. N. (2026). Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries. PLOS Neglected Tropical Diseases, 20(5), e0014310. https://doi.org/10.1371/journal.pntd.0014310
Vancouver
Vasconcelos LCM, Ossowski MS, Silva ED, Sampaio DD, Pavan TBS, Ferreira RQV, et al. Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries. PLOS Neglected Tropical Diseases. 2026;20(5):e0014310. doi:10.1371/journal.pntd.0014310
BibTeX
@article{Vasconcelos2026,
author = {Vasconcelos, Larissa de Carvalho Medrado and Ossowski, Micaela Soledad and Silva, Edimilson Domingos and Sampaio, Daniel Dias and Pavan, Tycha Bianca Sabaini and Ferreira, Randrin Queiroz Viana and Jesus, Felipe Silva Santos de and Chadi, Raúl and Fernández, Marisa Liliana and Hernández, Yolanda and Gómez, Karina Andrea and Santos, Fred Luciano Neves},
title = {Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {5},
pages = {e0014310},
doi = {10.1371/journal.pntd.0014310}
}
EUVIMED